Buy Asian Paints Ltd. at a price target of Rs 1245.0 and a stoploss at Rs 1130.0 from entry point

Buy Asian Paints Ltd. at a price target of Rs 1160.0 and a stop loss at Rs 1090.0 from entry point

Sell Asian Paints Ltd. at a price target of Rs 1025.0 and a stop loss at Rs 1060 from entry point

Aurobindo Pharma has appointed Sanjeev Dani, former senior executive with Ranbaxy Laboratories, as chief operating officer and head of form...

Dani and Gulati were part of the executive management committee, the apex leadership team responsible for running day-to-day operations.

Ranbaxy has inked a licensing pact with Cipher Pharmaceuticals Inc to exclusively market its isotretinoin capsules, used to treat acne, in ...

Ranbaxy Laboratories have entered into a licensing pact with EPIRUS Switzerland GmbH for treating rheumatoid arthiritis.

Drug major Ranbaxy Laboratories on Monday said it has launched a new chemical, Lulifin (Luliconazole), used in the treatment of fungal infe...

Ranbaxy Laboratories, India’s largest pharma company by sales, is looking to shift its marketing and administrative teams from its Gurgaon ...

Ranbaxy Laboratories has commenced Yemen operations in collaboration with local co Pharma Ltd, strengthening its presence in the Middle-Eas...

To strengthen its presence in the Middle-East, Ranbaxy Laboratories has started operations in Yemen by tying up with a local firm, Pharma.

Ranbaxy Laboratories Ltd on Thursday announced the launch of 'BONISTA- Teriparatide' injection used in the treatment of Osteoporosis diseas...

Country's largest drug maker Ranbaxy Laboratories said it has entered into an agreement with CD Pharma to market its drug INERSAN, used for...

Allergic rhinitis affects 10-25 per cent of the global population and is believed to be a precursor for Asthma, Ranbaxy said.

Ranbaxy Laboratories Ltd on Wednesday launched its a nasal spray Osonase (Ciclesonide) aqueous in India used in the treatment of perennial ...

Ranbaxy Labs on Monday announced the launch of two Novel Drug Delivery System (NDDS) products in the Urology Segment. Niftran 100mg Capsule...

Ranbaxy Laboratories Ltd on Tuesday announced the launch of its branded product, Avessa inhalation capsules in India for the treatment of A...